Compare Stocks

→ Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
OPTI Optec International	$0.00	$0.00	$0.00 ▼ $0.00	$43K	N/A	40.69 million shs	8.71 million shs
PDP Invesco Dorsey Wright Momentum ETF	$94.48 +0.7%	$95.49	$72.68 ▼ $99.60	$1.22B	1.02	26,020 shs	6,215 shs
SBM ProShares Short Basic Materials	$46.38	$46.38	$42.85 ▼ $55.15	$1.86M	N/A	3,024 shs	N/A
SBTX Silverback Therapeutics	$8.09 -2.1%	$8.82	$2.80 ▼ $8.97	$291.71M	0.6	337,931 shs	534,599 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
OPTI Optec International	+5.71%	+37.04%	-7.50%	+311.11%	+825.00%
PDP Invesco Dorsey Wright Momentum ETF	+0.06%	+1.91%	-4.59%	+7.89%	+27.55%
SBM ProShares Short Basic Materials	0.00%	0.00%	0.00%	0.00%	-0.01%
SBTX Silverback Therapeutics	-2.06%	-10.71%	-19.10%	+24.08%	+24.46%

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
OPTI Optec International	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SBM ProShares Short Basic Materials	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SBTX Silverback Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
OPTI Optec International	N/A	N/A	N/A	N/A
PDP Invesco Dorsey Wright Momentum ETF	0.00	N/A	$97.48	3.17% Upside
SBM ProShares Short Basic Materials	0.00	N/A	N/A	N/A
SBTX Silverback Therapeutics	N/A	N/A	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
OPTI Optec International	N/A	N/A	N/A	N/A	N/A	N/A
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	N/A	N/A	N/A	N/A
SBM ProShares Short Basic Materials	N/A	N/A	N/A	N/A	N/A	N/A
SBTX Silverback Therapeutics	N/A	N/A	N/A	N/A	$7.41 per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
OPTI Optec International	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	25.46	∞	N/A	N/A	N/A	N/A	N/A
SBM ProShares Short Basic Materials	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
SBTX Silverback Therapeutics	-$89.48M	-$2.42	N/A	∞	N/A	N/A	-29.62%	-28.20%	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
OPTI Optec International	N/A	N/A	N/A	N/A	N/A
PDP Invesco Dorsey Wright Momentum ETF	$0.25	0.26%	N/A	N/A	N/A
SBM ProShares Short Basic Materials	N/A	N/A	N/A	N/A	N/A
SBTX Silverback Therapeutics	N/A	N/A	N/A	N/A	N/A

Latest SBM, OPTI, SBTX, PDP, and DEST Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/15/2024	PDP Invesco Dorsey Wright Momentum ETF	Quarterly	$0.0275		3/18/2024	3/19/2024	3/22/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
OPTI Optec International	N/A	N/A	N/A
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	N/A
SBM ProShares Short Basic Materials	N/A	N/A	N/A
SBTX Silverback Therapeutics	N/A	67.87	67.87

Ownership

Institutional Ownership

Company	Institutional Ownership
OPTI Optec International	N/A
PDP Invesco Dorsey Wright Momentum ETF	N/A
SBM ProShares Short Basic Materials	N/A
SBTX Silverback Therapeutics	74.89%

Insider Ownership

Company	Insider Ownership
OPTI Optec International	50.34%
PDP Invesco Dorsey Wright Momentum ETF	N/A
SBM ProShares Short Basic Materials	N/A
SBTX Silverback Therapeutics	34.40%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
OPTI Optec International	1	11.65 million	N/A	Not Optionable
PDP Invesco Dorsey Wright Momentum ETF	N/A	12.89 million	N/A	Optionable
SBM ProShares Short Basic Materials	N/A	40,000	N/A	Not Optionable
SBTX Silverback Therapeutics	83	36.06 million	23.65 million	Not Optionable

SBM, OPTI, SBTX, PDP, and DEST Headlines

Source	Headline
	Silverback Therapeutics (NASDAQ:SBTX) Trading Down 2.8% americanbankingnews.com - April 25 at 1:48 AM
	Silverback Therapeutics (NASDAQ:SBTX) Trading Down 2% marketbeat.com - April 3 at 2:15 AM
	ARS Pharmaceuticals Inc (SPRY) uk.investing.com - May 11 at 1:32 PM
	Wild Isles wwf.org.uk - March 12 at 9:31 AM
	A look back at RNA Therapeutics – day one pharmaphorum.com - February 24 at 12:35 AM
	SPRY ARS Pharmaceuticals, Inc. seekingalpha.com - January 24 at 8:04 PM
	ARS Pharma CEO Richard Lowenthal Holds 8% Silverback Stake After Merger 247wallst.com - November 22 at 6:29 AM
	Dr. Sarina Tanimoto Discloses Position in SBTX / Silverback Therapeutics nasdaq.com - November 18 at 8:19 PM
	ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis finance.yahoo.com - November 10 at 6:41 PM
	ARS Pharmaceuticals Closes Merger with Silverback Therapeutics finance.yahoo.com - November 8 at 5:59 PM
	Silverback : FDA Accepts ARS Pharm's NDA For Neffy For Treatment Of Allergic Reactions markets.businessinsider.com - October 28 at 8:15 AM
	FDA accepts ARS Pharma’s NDA for Neffy thepharmaletter.com - October 24 at 10:29 AM
	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HIL, SBTX, COWN, AERI kentuckytoday.com - October 23 at 7:22 PM
	Silverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including Anaphylaxis finance.yahoo.com - October 21 at 7:59 AM
	Is Silverback Therapeutics Inc (SBTX) Stock a Good Investment? aaii.com - October 19 at 11:52 AM
	SHAREHOLDER ALERT: The M&A Class Action Firm is Investigating the Merger – RFP, SBTX, AAWW, COWN bakersfield.com - October 12 at 11:07 PM
	INVESTIGATION ALERT: Halper Sadeh LLC Investigates CVET, SBTX, IRBT markets.businessinsider.com - September 17 at 5:10 AM
	SBTX Silverback Therapeutics, Inc. seekingalpha.com - September 15 at 10:58 PM
	SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates FTAI, SBTX, CVET, GBT markets.businessinsider.com - September 6 at 11:53 AM
	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZY markets.businessinsider.com - August 23 at 6:32 PM
	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, HNGR, SBTX apnews.com - August 17 at 12:02 PM
	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates IEA, BBQ, SBTX apnews.com - August 11 at 1:33 AM
	SHAREHOLDER ALERT: Weiss Law Reminds SBTX, LJPC, CNVY, and DRE Shareholders About Its Ongoing Investigations morningstar.com - July 30 at 7:00 AM
	INVESTIGATION ALERT: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZY apnews.com - July 28 at 2:21 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

How to Use Put Debit Spreads to Profit From Falling Stocks
April 26, 2024 9:30 AM
View How to Use Put Debit Spreads to Profit From Falling Stocks
Delta Airline’s Put Option Activity Isn’t Bad News
March 28, 2024 8:55 AM
View Delta Airline’s Put Option Activity Isn’t Bad News
Here are the Pros and Cons of Using Options Call Debit Spreads
April 11, 2024 11:03 PM
View Here are the Pros and Cons of Using Options Call Debit Spreads
ASML Fires Warning Shot For Tech Investors
April 17, 2024 9:05 AM
View ASML Fires Warning Shot For Tech Investors
Robinhood’s Credit Card Has Call Option Buyers Coming in Hot
April 3, 2024 8:45 AM
View Robinhood’s Credit Card Has Call Option Buyers Coming in Hot

All Headlines

Company Descriptions

Optec International

OTCMKTS:OPTI

Optec International, Inc. engages in selling and marketing optimized fuel maximizer units in North America and internationally. It markets optimized fuel maximizer for passenger vehicles, intermediate/medium duty trucks, off-road equipment, generator systems, heavy duty diesel on-road vehicles, and transportation refrigeration units. The company was formerly known as Green Meadow Products, Inc. and changed its name to Optec International, Inc. in August 2017. Optec International, Inc. was founded in 2012 and is based in Carlsbad, California.

Invesco Dorsey Wright Momentum ETF

NASDAQ:PDP

PowerShares DWA Technical Leaders Portfolio (the Fund) is based on the Dorsey Wright Technical Leaders Index (the Index). The Fund seeks investment results that generally correspond to the price and yield of the Index. The Fund will normally invest at least 90% of its total assets in securities that consists of the Index and American Depositary Receipts (ADRs) based on the securities in the Index. The Index includes approximately 100 the United States-listed companies. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser.

ProShares Short Basic Materials

NYSEARCA:SBM

ProShares Short Basic Materials (the Fund) seeks daily investment results that correspond to the inverse (opposite) of the daily performance of Dow Jones U.S. Basic Materials Index (the Index). The Index measures the performance of the basic materials industry of the United States equity market. The Fund invests in derivatives as a substitute for directly shorting stocks in order to gain inverse exposure to the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. The Fund also invests in short-term cash instruments that have terms to maturity of less than 397 days and exhibit credit profiles. ProShare Advisors LLC is the investment advisor of the Fund.

Silverback Therapeutics

NASDAQ:SBTX

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial